News and Press Releases

Er-Kim Announces Exclusive Distribution Agreement with the MEDICE Health Family For Vafseo in Central & Eastern Europe

Collaboration will support access of an alternative treatment to improve the lives of people impacted by anemia caused by chronic kidney disease 14 January 2025 -- Warsaw, Poland -- Er-Kim,...

Category: Drug Delivery, Logistics, Other, Pharmaceutical
Posted: January 14, 2025

Akat Mah. Ebulula Mardin Cad. Maya Meridien İş Merkezi No: 16 Daire: 25 34335 Beşiktaş/İstanbul

CN Bio signs strategic partnership with Primetech Corporation to establish distribution channel for OOC solutions in Japan

Agreement establishes direct distribution channel for customers in Japan, providing local support and expertise Partnership solidifies CN Bio’s presence in Asian markets and supports ongoing global expansion. 14 January 2025...

Category: Biotechnology, Logistics, Other, Pharmaceutical
Posted: January 14, 2025

30 Upper High Street, Thame, Oxfordshire, OX9 3EZ

Santhera Enters into Supply and Distribution Agreement for AGAMREE (Vamorolone) with Clinigen Group

6 January 2025 -- Pratteln, Switzerland -- Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE (vamorolone) in countries...

Category: Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 6, 2025

Santhera Pharmaceuticals Headquarters Hohenrainstrasse 24 | 4133 Pratteln | Switzerland

GSK’s Omjjara▼ (momelotinib) is accepted for use within NHS Scotland, in line with its licence, for eligible adult myelofibrosis patients with moderate to severe anaemia

Clinicians in Scotland will now have the option to use momelotinib for the treatment of disease-related splenomegaly or symptoms in adult myelofibrosis patients with moderate to severe anaemia Momelotinib is...

Category: Other, Pharmaceutical
Posted: June 10, 2024

980 Great West Rd, London TW8 9GS